Growth rate-corrected (GR) dose-response metric signatures across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 3 of 4: Median, upper quartile, and lower quartile GR metrics per perturbagen. - Dataset (ID:20270)

Small Molecules Studied

HMS LINCS ID Name Alternative Names LINCS ID Structure Image PubChem CID
10277-1 Temsirolimus LSM-4295 148191
10278-1 Topotecan
Hycamtin
LSM-5662 60700
10279-1 Trichostatin A LSM-43005
10280-1 Triciribine LSM-3810 65399
10281-1 Vinorelbine
Navelbine
LSM-6302 5311497
10282-1 Vorinostat
suberoylanilide hydroxamic acid (SAHA); Zolinza
LSM-3828 5311
10283-1 XRP44X
AG-G-87906
LSM-4298 10339779
10343-1 Baicalein LSM-6355 5281605
10344-1 Olomoucine II LSM-6356 10067756
10345-3 Torkinib
PP242
LSM-6357 57347681
10346-1 Valproic acid
Depakine
LSM-4620 3549980
10348-1 Z-Leu-Leu-Norvalinal
MG-115
LSM-6358 9868928
10506-1 Dichloroacetate 25975
10507-1 Disulfiram
Tetraethylthiuram disulfide; TETD
3117
10508-1 FTase Inhibitor I
B581
132887
10511-1 Mebendazole
Vermox
4030
10513-1 Nelfinavir
Viracept
64143
10514-1 PS-1145 9949093
10516-1 Ribavirin
Tribavirin
37542
10520-1 TCS PIM-1 1 1235170